Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers

Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers

Background: B-Cell Lymphoma-2 gene is an anti-apoptotic protein associated with favorable prognosis in patients with breast cancer. The present study focused on immunohistochemical expression of the aforementioned gene with clinicopathological correlation in non-triple negative breast cancers (NTNBC...

Full description

Bibliographic Details
Main Authors:	Muhammad Zubair, Iqbal Muhammad, Hassan Tariq, Rabia Ahmad, Akhter Ali, Salma Gul
Format:	Article
Language:	English
Published:	Kaviani Breast Disease Institute 2017-06-01
Series:	Archives of Breast Cancer
Subjects:	B-Cell Lymphoma-2 (BCL-2) Non-Triple Negative Breast Cancers (NTNBcs) Triple Negative Breast Cancers (TNBCs) Immunohistochemistry (IHC)
Online Access:	https://archbreastcancer.com/index.php/abc/article/view/130

Similar Items

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
by: Magdalena Niedolistek, et al.
Published: (2020-04-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
by: Srijan Basu, et al.
Published: (2023-11-01)

Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
by: Abdulwahab Abuderman, et al.
Published: (2020-07-01)

Current approaches in treatment of triple-negative breast cancer
by: Hanan Ahmed Wahba, et al.
Published: (2015-06-01)

Correlation between the Expression of PD-L1 and Clinicopathological Parameters in Triple Negative Breast Cancer Patients
by: Rabia Doğukan, et al.
Published: (2019-10-01)

High claudin-4 antigen expression in triple-negative breast cancer by the immunohistochemistry method
by: Azar Naimi, et al.
Published: (2022-01-01)

Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
by: Dubrava AL, et al.
Published: (2023-05-01)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
by: Marisa Leeha, et al.
Published: (2023-05-01)

A clinical analysis of clinicopathological features and prognostic factors of triple-negative breast cancer
by: Oana-Adriana Rajput-Anghel, et al.
Published: (2024-03-01)

The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience
by: Yeşim Eralp, et al.
Published: (2014-10-01)

Presentation and treatment of aggressive, Triple‐Negative carcinosarcoma of the breast
by: Niels Vizgan, et al.
Published: (2022-07-01)

Platinum chemotherapy for early triple-negative breast cancer
by: Sofia RE. Mason, et al.
Published: (2024-06-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Components of the tumor immune microenvironment based on m‐IHC correlate with prognosis and subtype of triple‐negative breast cancer
by: Luyi Lin, et al.
Published: (2023-12-01)

Beyond Triple-Negative: High Prevalence of Quadruple-Negative Breast Cancer in African Americans
by: Oluwadamilola Oladeru, et al.
Published: (2024-07-01)

Response to cisplatin in a metastatic triple-negative breast cancer patient
by: Budhi Singh Yadav, et al.
Published: (2021-01-01)

Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
by: Sylvia Annabel Dass, et al.
Published: (2021-01-01)

Clinicopathological Characteristics and Androgen Receptor Expression of Triple Negative Breast Cancer: A Retrospective Study in Upper Egypt
by: Eman Mostafa Masoud*, et al.
Published: (2021-08-01)

Immunohistochemical Profile and Morphology in Triple – Negative Breast Cancers
by: Chandrika Rao, et al.
Published: (2013-07-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021-08-01)

Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient
by: Nicole Brunetti, et al.
Published: (2023-01-01)

Potential action of cardamom (Elettaria cardamomum) against triple-negative breast cancer
by: Akash Samanta, et al.
Published: (2023-01-01)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
by: Yi-Fen Chiang, et al.
Published: (2023-01-01)

Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer
by: Shuai Ge, et al.
Published: (2022-09-01)

Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway
by: Chengwu Zhang, et al.
Published: (2024-02-01)

Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer
by: Yeonjin Jeon, et al.
Published: (2022-09-01)

A case report and literature review on a rare subtype of triple-negative breast cancer in children
by: Lexiang Shi, et al.
Published: (2023-09-01)

Clinicopathological Features and Treatment Challenges in Triple Negative Breast Cancer Patients: A Retrospective Cohort Study
by: Amira ELWAN, et al.
Published: (2021-05-01)

Functional exploration of copy number alterations in a Drosophila model of triple-negative breast cancer
by: Jennifer E. L. Diaz, et al.
Published: (2024-07-01)

Design, Synthesis, and Evaluation of Novel Cryptotanshinone Derivatives for Activity against Triple-Negative Breast Cancer
by: Siyu Liu, et al.
Published: (2024-06-01)

Profile and Outcome of Triple Negative Breast Cancer at a Tertiary Care University Hospital in Nepal
by: Suman Khanal, et al.
Published: (2020-06-01)

Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer
by: Mei Zhu, et al.
Published: (2023-03-01)

Current and emerging treatment options in triple-negative breast cancer
by: Omer Dizdar, et al.
Published: (2011-12-01)

Elevated mRNA expression levels of inflammation-related genes in triple-negative breast cancer: A pilot study from North East India
by: Rizwana Sultana, et al.
Published: (2021-01-01)

Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer
by: Anna Badowska-Kozakiewicz, et al.
Published: (2018-11-01)

Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran
by: Mehrzad Mirzania, et al.
Published: (2016-12-01)

Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
by: So-Woon Kim, et al.
Published: (2021-08-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

Epidemiological Profile and Clinicopathological Correlates of Triple Negative Breast Cancer Patients at Regional Cancer Centre
by: Richa Verma, et al.
Published: (2021-11-01)

Research Progress on Ferroptosis and Nanotechnology-Based Treatment in Triple-Negative Breast Cancer
by: Zhang J, et al.
Published: (2024-07-01)